S&P 500   2,628.31 (+5.61%)
DOW   22,245.88 (+5.67%)
QQQ   193.20 (+5.36%)
AAPL   253.88 (+5.17%)
FB   162.23 (+5.22%)
MSFT   161.52 (+5.00%)
GOOGL   1,153.87 (+5.60%)
AMZN   1,968.53 (+3.25%)
CGC   14.01 (+5.74%)
NVDA   261.94 (+7.39%)
MU   44.82 (+8.73%)
GE   7.16 (+6.24%)
TSLA   511.50 (+6.56%)
AMD   46.21 (+8.50%)
T   29.07 (+5.86%)
ACB   0.82 (+1.24%)
F   4.56 (+7.55%)
BAC   21.22 (+5.94%)
GILD   76.49 (-2.20%)
DIS   97.85 (+4.23%)
S&P 500   2,628.31 (+5.61%)
DOW   22,245.88 (+5.67%)
QQQ   193.20 (+5.36%)
AAPL   253.88 (+5.17%)
FB   162.23 (+5.22%)
MSFT   161.52 (+5.00%)
GOOGL   1,153.87 (+5.60%)
AMZN   1,968.53 (+3.25%)
CGC   14.01 (+5.74%)
NVDA   261.94 (+7.39%)
MU   44.82 (+8.73%)
GE   7.16 (+6.24%)
TSLA   511.50 (+6.56%)
AMD   46.21 (+8.50%)
T   29.07 (+5.86%)
ACB   0.82 (+1.24%)
F   4.56 (+7.55%)
BAC   21.22 (+5.94%)
GILD   76.49 (-2.20%)
DIS   97.85 (+4.23%)
S&P 500   2,628.31 (+5.61%)
DOW   22,245.88 (+5.67%)
QQQ   193.20 (+5.36%)
AAPL   253.88 (+5.17%)
FB   162.23 (+5.22%)
MSFT   161.52 (+5.00%)
GOOGL   1,153.87 (+5.60%)
AMZN   1,968.53 (+3.25%)
CGC   14.01 (+5.74%)
NVDA   261.94 (+7.39%)
MU   44.82 (+8.73%)
GE   7.16 (+6.24%)
TSLA   511.50 (+6.56%)
AMD   46.21 (+8.50%)
T   29.07 (+5.86%)
ACB   0.82 (+1.24%)
F   4.56 (+7.55%)
BAC   21.22 (+5.94%)
GILD   76.49 (-2.20%)
DIS   97.85 (+4.23%)
S&P 500   2,628.31 (+5.61%)
DOW   22,245.88 (+5.67%)
QQQ   193.20 (+5.36%)
AAPL   253.88 (+5.17%)
FB   162.23 (+5.22%)
MSFT   161.52 (+5.00%)
GOOGL   1,153.87 (+5.60%)
AMZN   1,968.53 (+3.25%)
CGC   14.01 (+5.74%)
NVDA   261.94 (+7.39%)
MU   44.82 (+8.73%)
GE   7.16 (+6.24%)
TSLA   511.50 (+6.56%)
AMD   46.21 (+8.50%)
T   29.07 (+5.86%)
ACB   0.82 (+1.24%)
F   4.56 (+7.55%)
BAC   21.22 (+5.94%)
GILD   76.49 (-2.20%)
DIS   97.85 (+4.23%)
Log in

NASDAQ:ACIUAC Immune SEC Filings & 10K Form

$6.93
-0.58 (-7.72 %)
(As of 04/6/2020 12:20 PM ET)
Add
Compare
Today's Range
$6.86
Now: $6.93
$7.62
50-Day Range
$4.24
MA: $6.71
$8.65
52-Week Range
$4.07
Now: $6.93
$10.14
Volume7,066 shs
Average Volume177,639 shs
Market Capitalization$468.19 million
P/E Ratio10.83
Dividend YieldN/A
Beta0.54

SEC Filings

AC Immune (NASDAQ:ACIU) SEC Filings

DateFilerForm TypeView
04/02/2020
6:11 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2020
8:08 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2020
8:04 AM
AC Immune (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/23/2020
7:15 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2020
2:07 PM
AC Immune (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
02/06/2020
2:16 PM
AC Immune (Subject)
dievini Hopp BioTech holding GmbH & Co KG (Filed by)
Form SC 13G/A
11/13/2019
5:34 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2019
5:48 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2019
6:53 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2019
4:16 PM
AC Immune (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
08/14/2019
7:15 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2019
3:18 PM
AC Immune (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2019
6:55 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2019
7:08 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2019
7:20 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2019
3:45 PM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2019
6:22 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2019
6:43 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2019
4:07 PM
AC Immune (Filer)
Form 20-F/A
03/21/2019
4:10 PM
AC Immune (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
03/21/2019
6:51 AM
AC Immune (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/21/2019
6:44 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2019
8:00 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2019
3:30 PM
AC Immune (Subject)
Varuma AG (Filed by)
Form SC 13G/A
02/08/2019
5:02 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2019
8:38 AM
AC Immune (Subject)
dievini Hopp BioTech holding GmbH & Co KG (Filed by)
Form SC 13G/A
01/30/2019
5:00 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2019
5:36 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/03/2019
5:22 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2018
5:04 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2018
3:28 PM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2018
5:05 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/26/2018
4:01 PM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2018
5:59 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2018
11:15 PM
AC Immune (Filer)
Form EFFECT
08/24/2018
4:14 PM
AC Immune (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
08/08/2018
5:01 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2018
4:04 PM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2018
3:06 PM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/20/2018
5:03 AM
AC Immune (Filer)
Form 424B5
07/19/2018
3:17 PM
AC Immune (Filer)
Form 424B5
07/17/2018
3:08 PM
AC Immune (Filer)
Form 424B5
07/17/2018
5:00 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2018
3:37 PM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2018
11:15 PM
AC Immune (Filer)
Form EFFECT
06/07/2018
3:06 PM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/25/2018
5:31 AM
AC Immune (Filer)
Form F-3/A
05/04/2018
4:25 PM
AC Immune (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
05/02/2018
5:00 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/27/2018
3:43 PM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2018
3:37 PM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2018
6:07 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2018
5:03 AM
AC Immune (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/20/2018
5:00 AM
AC Immune (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: What is a management fee?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel